Global Thin Film Drugs Market Analysis and Forecast 2024-2030

Global Thin Film Drugs Market Analysis and Forecast 2024-2030


Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.

According to APO Research, The global Thin Film Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Thin Film Drugs key players include GSK, LTS, J&J, Indivior, Pfizer, etc. Global top five manufacturers hold a share over 35%.

Europe is the largest market, with a share about 40%, followed by Asia-Pacific, and North America, both have a share about 45 percent.

In terms of product, Transdermal Film is the largest segment, with a share over 70%. And in terms of application, the largest application is Drugstores, followed by Hospitals, etc.

Report Includes

This report presents an overview of global market for Thin Film Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Thin Film Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Thin Film Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Thin Film Drugs revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Thin Film Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Thin Film Drugs revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec and Tapemark, etc.

Thin Film Drugs segment by Company

GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR

Thin Film Drugs segment by Type

Transdermal Film
Oral Thin Film
Others

Thin Film Drugs segment by Application

Hospitals
Drugstores
Others

Thin Film Drugs segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thin Film Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Thin Film Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thin Film Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Thin Film Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Thin Film Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Thin Film Drugs revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Thin Film Drugs Market by Type
1.2.1 Global Thin Film Drugs Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Transdermal Film
1.2.3 Oral Thin Film
1.2.4 Others
1.3 Thin Film Drugs Market by Application
1.3.1 Global Thin Film Drugs Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Thin Film Drugs Market Dynamics
2.1 Thin Film Drugs Industry Trends
2.2 Thin Film Drugs Industry Drivers
2.3 Thin Film Drugs Industry Opportunities and Challenges
2.4 Thin Film Drugs Industry Restraints
3 Global Growth Perspective
3.1 Global Thin Film Drugs Market Perspective (2019-2030)
3.2 Global Thin Film Drugs Growth Trends by Region
3.2.1 Global Thin Film Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Thin Film Drugs Market Size by Region (2019-2024)
3.2.3 Global Thin Film Drugs Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Thin Film Drugs Revenue by Players
4.1.1 Global Thin Film Drugs Revenue by Players (2019-2024)
4.1.2 Global Thin Film Drugs Revenue Market Share by Players (2019-2024)
4.1.3 Global Thin Film Drugs Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Thin Film Drugs Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Thin Film Drugs Key Players Headquarters & Area Served
4.4 Global Thin Film Drugs Players, Product Type & Application
4.5 Global Thin Film Drugs Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Thin Film Drugs Market CR5 and HHI
4.6.2 Global Top 5 and 10 Thin Film Drugs Players Market Share by Revenue in 2023
4.6.3 2023 Thin Film Drugs Tier 1, Tier 2, and Tier 3
5 Thin Film Drugs Market Size by Type
5.1 Global Thin Film Drugs Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Thin Film Drugs Revenue by Type (2019-2030)
5.3 Global Thin Film Drugs Revenue Market Share by Type (2019-2030)
6 Thin Film Drugs Market Size by Application
6.1 Global Thin Film Drugs Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Thin Film Drugs Revenue by Application (2019-2030)
6.3 Global Thin Film Drugs Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.1.4 GSK Thin Film Drugs Product Portfolio
7.1.5 GSK Recent Developments
7.2 LTS
7.2.1 LTS Comapny Information
7.2.2 LTS Business Overview
7.2.3 LTS Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.2.4 LTS Thin Film Drugs Product Portfolio
7.2.5 LTS Recent Developments
7.3 J&J
7.3.1 J&J Comapny Information
7.3.2 J&J Business Overview
7.3.3 J&J Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.3.4 J&J Thin Film Drugs Product Portfolio
7.3.5 J&J Recent Developments
7.4 Indivior
7.4.1 Indivior Comapny Information
7.4.2 Indivior Business Overview
7.4.3 Indivior Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.4.4 Indivior Thin Film Drugs Product Portfolio
7.4.5 Indivior Recent Developments
7.5 Pfizer
7.5.1 Pfizer Comapny Information
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.5.4 Pfizer Thin Film Drugs Product Portfolio
7.5.5 Pfizer Recent Developments
7.6 Sanofi
7.6.1 Sanofi Comapny Information
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.6.4 Sanofi Thin Film Drugs Product Portfolio
7.6.5 Sanofi Recent Developments
7.7 Church & Dwight
7.7.1 Church & Dwight Comapny Information
7.7.2 Church & Dwight Business Overview
7.7.3 Church & Dwight Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.7.4 Church & Dwight Thin Film Drugs Product Portfolio
7.7.5 Church & Dwight Recent Developments
7.8 tesa Labtec
7.8.1 tesa Labtec Comapny Information
7.8.2 tesa Labtec Business Overview
7.8.3 tesa Labtec Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.8.4 tesa Labtec Thin Film Drugs Product Portfolio
7.8.5 tesa Labtec Recent Developments
7.9 Tapemark
7.9.1 Tapemark Comapny Information
7.9.2 Tapemark Business Overview
7.9.3 Tapemark Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.9.4 Tapemark Thin Film Drugs Product Portfolio
7.9.5 Tapemark Recent Developments
7.10 Prestige Bands
7.10.1 Prestige Bands Comapny Information
7.10.2 Prestige Bands Business Overview
7.10.3 Prestige Bands Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.10.4 Prestige Bands Thin Film Drugs Product Portfolio
7.10.5 Prestige Bands Recent Developments
7.11 Sun Pharma
7.11.1 Sun Pharma Comapny Information
7.11.2 Sun Pharma Business Overview
7.11.3 Sun Pharma Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.11.4 Sun Pharma Thin Film Drugs Product Portfolio
7.11.5 Sun Pharma Recent Developments
7.12 MonoSol
7.12.1 MonoSol Comapny Information
7.12.2 MonoSol Business Overview
7.12.3 MonoSol Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.12.4 MonoSol Thin Film Drugs Product Portfolio
7.12.5 MonoSol Recent Developments
7.13 BioDelivery
7.13.1 BioDelivery Comapny Information
7.13.2 BioDelivery Business Overview
7.13.3 BioDelivery Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.13.4 BioDelivery Thin Film Drugs Product Portfolio
7.13.5 BioDelivery Recent Developments
7.14 Arx
7.14.1 Arx Comapny Information
7.14.2 Arx Business Overview
7.14.3 Arx Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.14.4 Arx Thin Film Drugs Product Portfolio
7.14.5 Arx Recent Developments
7.15 ZIM
7.15.1 ZIM Comapny Information
7.15.2 ZIM Business Overview
7.15.3 ZIM Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.15.4 ZIM Thin Film Drugs Product Portfolio
7.15.5 ZIM Recent Developments
7.16 NAL Pharma
7.16.1 NAL Pharma Comapny Information
7.16.2 NAL Pharma Business Overview
7.16.3 NAL Pharma Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.16.4 NAL Pharma Thin Film Drugs Product Portfolio
7.16.5 NAL Pharma Recent Developments
7.17 AdhexPharma
7.17.1 AdhexPharma Comapny Information
7.17.2 AdhexPharma Business Overview
7.17.3 AdhexPharma Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.17.4 AdhexPharma Thin Film Drugs Product Portfolio
7.17.5 AdhexPharma Recent Developments
7.18 Aavishkar
7.18.1 Aavishkar Comapny Information
7.18.2 Aavishkar Business Overview
7.18.3 Aavishkar Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.18.4 Aavishkar Thin Film Drugs Product Portfolio
7.18.5 Aavishkar Recent Developments
7.19 IntelGenx Corp
7.19.1 IntelGenx Corp Comapny Information
7.19.2 IntelGenx Corp Business Overview
7.19.3 IntelGenx Corp Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.19.4 IntelGenx Corp Thin Film Drugs Product Portfolio
7.19.5 IntelGenx Corp Recent Developments
7.20 APR
7.20.1 APR Comapny Information
7.20.2 APR Business Overview
7.20.3 APR Thin Film Drugs Revenue and Gross Margin (2019-2024)
7.20.4 APR Thin Film Drugs Product Portfolio
7.20.5 APR Recent Developments
8 North America
8.1 North America Thin Film Drugs Revenue (2019-2030)
8.2 North America Thin Film Drugs Revenue by Type (2019-2030)
8.2.1 North America Thin Film Drugs Revenue by Type (2019-2024)
8.2.2 North America Thin Film Drugs Revenue by Type (2025-2030)
8.3 North America Thin Film Drugs Revenue Share by Type (2019-2030)
8.4 North America Thin Film Drugs Revenue by Application (2019-2030)
8.4.1 North America Thin Film Drugs Revenue by Application (2019-2024)
8.4.2 North America Thin Film Drugs Revenue by Application (2025-2030)
8.5 North America Thin Film Drugs Revenue Share by Application (2019-2030)
8.6 North America Thin Film Drugs Revenue by Country
8.6.1 North America Thin Film Drugs Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Thin Film Drugs Revenue by Country (2019-2024)
8.6.3 North America Thin Film Drugs Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Thin Film Drugs Revenue (2019-2030)
9.2 Europe Thin Film Drugs Revenue by Type (2019-2030)
9.2.1 Europe Thin Film Drugs Revenue by Type (2019-2024)
9.2.2 Europe Thin Film Drugs Revenue by Type (2025-2030)
9.3 Europe Thin Film Drugs Revenue Share by Type (2019-2030)
9.4 Europe Thin Film Drugs Revenue by Application (2019-2030)
9.4.1 Europe Thin Film Drugs Revenue by Application (2019-2024)
9.4.2 Europe Thin Film Drugs Revenue by Application (2025-2030)
9.5 Europe Thin Film Drugs Revenue Share by Application (2019-2030)
9.6 Europe Thin Film Drugs Revenue by Country
9.6.1 Europe Thin Film Drugs Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Thin Film Drugs Revenue by Country (2019-2024)
9.6.3 Europe Thin Film Drugs Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Thin Film Drugs Revenue (2019-2030)
10.2 China Thin Film Drugs Revenue by Type (2019-2030)
10.2.1 China Thin Film Drugs Revenue by Type (2019-2024)
10.2.2 China Thin Film Drugs Revenue by Type (2025-2030)
10.3 China Thin Film Drugs Revenue Share by Type (2019-2030)
10.4 China Thin Film Drugs Revenue by Application (2019-2030)
10.4.1 China Thin Film Drugs Revenue by Application (2019-2024)
10.4.2 China Thin Film Drugs Revenue by Application (2025-2030)
10.5 China Thin Film Drugs Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Thin Film Drugs Revenue (2019-2030)
11.2 Asia Thin Film Drugs Revenue by Type (2019-2030)
11.2.1 Asia Thin Film Drugs Revenue by Type (2019-2024)
11.2.2 Asia Thin Film Drugs Revenue by Type (2025-2030)
11.3 Asia Thin Film Drugs Revenue Share by Type (2019-2030)
11.4 Asia Thin Film Drugs Revenue by Application (2019-2030)
11.4.1 Asia Thin Film Drugs Revenue by Application (2019-2024)
11.4.2 Asia Thin Film Drugs Revenue by Application (2025-2030)
11.5 Asia Thin Film Drugs Revenue Share by Application (2019-2030)
11.6 Asia Thin Film Drugs Revenue by Country
11.6.1 Asia Thin Film Drugs Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Thin Film Drugs Revenue by Country (2019-2024)
11.6.3 Asia Thin Film Drugs Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Thin Film Drugs Revenue (2019-2030)
12.2 MEALA Thin Film Drugs Revenue by Type (2019-2030)
12.2.1 MEALA Thin Film Drugs Revenue by Type (2019-2024)
12.2.2 MEALA Thin Film Drugs Revenue by Type (2025-2030)
12.3 MEALA Thin Film Drugs Revenue Share by Type (2019-2030)
12.4 MEALA Thin Film Drugs Revenue by Application (2019-2030)
12.4.1 MEALA Thin Film Drugs Revenue by Application (2019-2024)
12.4.2 MEALA Thin Film Drugs Revenue by Application (2025-2030)
12.5 MEALA Thin Film Drugs Revenue Share by Application (2019-2030)
12.6 MEALA Thin Film Drugs Revenue by Country
12.6.1 MEALA Thin Film Drugs Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Thin Film Drugs Revenue by Country (2019-2024)
12.6.3 MEALA Thin Film Drugs Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings